| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
101,390,000 |
| Market
Cap: |
1.64(B) |
| Last
Volume: |
668,805 |
Avg
Vol: |
666,996 |
| 52
Week Range: |
$12.32 - $16.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Innoviva is a company with a portfolio of royalties and other healthcare assets. Co.'s royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and TRELEGY® ELLIPTA®. Co. is entitled to royalty payments made by GSK under its agreements that assigned to Theravance Respiratory Company, LLC (TRC), including TRELEGY® ELLIPTA® and any other product or combination of products that may be discovered or developed in the future under the Long-Acting Beta2 Agonist Collaboration Agreement and the Strategic Alliance Agreement with GSK, which have been assigned to TRC other than RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
664,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$8,468,005 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
12 |
| Total Shares Sold |
0 |
0 |
10,994 |
10,994 |
| Total Sell Value |
$0 |
$0 |
$153,810 |
$153,810 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mammen Mathai |
Senior VP, Research |
• – – |
2009-02-20 |
4 |
D |
$14.87 |
$17,591 |
D/D |
(1,183) |
67,886 |
|
- |
|
| Aguiar Michael W |
Sr VP, Chief Financial Officer |
• – – |
2009-02-20 |
4 |
D |
$14.87 |
$35,242 |
D/D |
(2,370) |
62,026 |
|
- |
|
| Winningham Rick E |
Chief Executive Officer |
• • – |
2009-02-20 |
4 |
D |
$14.87 |
$31,346 |
D/D |
(2,108) |
41,010 |
|
- |
|
| Shafer Bradford J |
Sr VP, Gen. Counsel, Secretary |
• – – |
2009-02-20 |
4 |
D |
$14.87 |
$8,595 |
D/D |
(578) |
192,690 |
|
- |
|
| Shafer Bradford J |
Sr VP, Gen. Counsel, Secretary |
• – – |
2008-07-30 |
4 |
S |
$15.97 |
$553,689 |
D/D |
(34,676) |
193,268 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2008-06-04 |
4 |
S |
$13.00 |
$195,174 |
D/D |
(15,000) |
30,738 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2008-06-04 |
4 |
OE |
$8.53 |
$127,875 |
D/D |
15,000 |
45,738 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2008-06-03 |
4 |
S |
$13.00 |
$16,971 |
D/D |
(1,300) |
30,738 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2008-06-03 |
4 |
OE |
$3.10 |
$7,529 |
D/D |
1,300 |
32,038 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2008-06-02 |
4 |
S |
$13.00 |
$48,120 |
D/D |
(3,700) |
30,738 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2008-06-02 |
4 |
OE |
$3.10 |
$11,470 |
D/D |
3,700 |
34,438 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
33,866 |
|
- |
|
| Vagelos P Roy |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
28,898 |
673,968 |
|
- |
|
| Young William D |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
|
- |
|
| Waltrip William H |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
|
- |
|
| Whitesides George M |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
543,419 |
|
- |
|
| Levine Arnold J |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
69,967 |
|
- |
|
| Malkiel Burton G |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
|
- |
|
| Gunderson Robert V Jr |
Director |
– • – |
2008-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
53,396 |
|
- |
|
| Vagelos P Roy |
Director |
– • – |
2008-03-14 |
4 |
B |
$10.23 |
$177,359 |
D/D |
17,300 |
71,499 |
2.39 |
- |
|
| Vagelos P Roy |
Director |
– • – |
2008-03-14 |
4 |
B |
$10.13 |
$78,485 |
D/D |
7,700 |
54,199 |
2.39 |
- |
|
| Vagelos P Roy |
Director |
– • – |
2008-03-13 |
4 |
B |
$10.45 |
$252,852 |
D/D |
24,000 |
46,499 |
2.39 |
- |
|
| Winningham Rick E |
Chief Executive Officer |
• • – |
2008-03-11 |
4 |
B |
$10.40 |
$209,421 |
D/D |
20,000 |
43,118 |
2.81 |
- |
|
| Blum Leonard M |
Sr VP, Chief Comm. Officer |
• – – |
2008-03-10 |
4 |
B |
$9.97 |
$307,698 |
D/D |
28,385 |
91,996 |
2.74 |
- |
|
| Mammen Mathai |
Senior VP, Research |
• – – |
2008-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
69,069 |
|
- |
|
704 Records found
|
|
Page 25 of 29 |
|
|
0.06 (0.37%) 
